IP Misconceptions & The True Value of a Patent:
Optimising your IP protection when looking for investment
š
Ā Date: 29.08.2024
šĀ Time: 13:00 ā 14:00 CET
šĀ In this webinar, we will go through the main misconceptions that patent attorneys often see:
- You have a patent, so you are free to use your invention, arenāt you?
- Getting a patent granted is hard
- You need to file many patent applications early in your development work
- You want to get your patents granted quickly
- Your invention is in the software area, so you wonāt be able to get a patent
- You need to get āworld-wideā protection for your invention
Who Should Attend?
š„Ā Startups and scale-upsš©āš¼Ā Founders and CEOsĀ šĀ Business Development ProfessionalsĀ šĀ Anyone eyeing exponential growth through strategic partnerships
Speakers Include:
Paul Brady: European and UK Patent Attorney and a Partner in the Patent Attorney Firm, Abel & Imray, London. Paulās background is in chemistry and biotechnology and he mostly handles patent work in the pharmaceuticals area.Ā He particularly works with medium sized companies taking drug candidates through the pre-clinical and clinical development process.Ā As well as helping originator companies optimise their patent portfolios, Paul regularly assists investors with assessing the patent positions of target companies.
Julia Coggins: European and UK Patent Attorney and also a Partner in Abel & Imray, London. Ā Julia is a chemist and mostly works with clients in the pharmaceutical field, both academic institutions and commercial companies.Ā As well as drug compounds, her work also covers diagnostic tests and prognostic methods.Ā In addition to working with clients on their patent portfolios as they take drug candidates through the pre-clinical and clinical development process, Julia regularly provides advice to clients in partnering discussions in relation to the treatment and value of their patent assets.
Tom Burt: European and UK Patent Attorney, and also a Partner in Abel & Imray, London. Tomās technical background is in mathematics and computing.Ā He handles software, electronic and mechanical patent work, and specialises in software, including artificial intelligence, machine learning and its use in biotech. Ā He is particularly experienced in the law relating to excluded subject matter, and what software inventions can and cannot be patented.Ā Tom regularly works with growing companies and advises on the steps they take during various stages of investment.
Fredrik Lehmann: Entrepreneur in residence at Sound Bioventures & Venture Partner in Life Science at Industrifonden. Fredrik focuses on life science, with an extra eye for innovative biotechs. He is interested in contributing to businesses with his experience from the biotech world to help companies reach their highest potential. Fredrik has more than 20 years of experience from the life science industry; Ā as CEO, Head of Research and CMC in several companies. He has extensive experience from turning ideas into products and successful businesses, and have founded six companies
Karin Leire: Investment director at Segulah Medical Acceleration (SMA), a Swedish growth equity company investing in cutting-edge medtech companies, bridging innovation and commercial validation for medical devices, diagnostics, health tech and life science tools. Karin specializes in clinical research and evidence-based product development, with many years of experience in the Nordic CRO industry and until 2023 as VP of Research & Innovation at Permobil group. She holds a master degree of biomedical sciences at the University of Uppsala, Sweden.
š¤ The āInvestor Readiness Webinar Series 2024ā is part of a collaboration between five clusters within health- and life science aiming to provide increased knowledge of & readiness for the investor universe.
